Previous 10 | Next 10 |
home / stock / bayry / bayry news
Bayer ( OTCPK:BAYRY ) has agreed to buy 70% of online vitamin and health supplement company Care/of in a deal that values the company at $225M, with an option to buy the rest by 2022, Bloomberg reports. More news on: Bayer Aktiengesellschaft, Bayer Aktiengesellschaft, Healthcare stocks...
Step One: Wide-moat stocks with 5-star and 4-star ratings Historical evidence says that, while quality alone is a poor indicator of outperformance, when combined with a decent valuation filter, Morningstar's moat rating proves to be more than useful. Based on the available data, stocks wit...
Bayer ( OTCPK:BAYRY ) acknowledges "bumps" in finalizing its $11B settlement of thousands of U.S. lawsuits over its Roundup weedkiller after the judge overseeing the litigation cast doubt on the progress of the agreement. More news on: Bayer Aktiengesellschaft, Read more ...
Bayer ( OTCPK:BAYRY -2.3% ) slides after the judge overseeing consumer lawsuits involving its Roundup weedkiller says he has received several confidential letters from plaintiffs' lawyers complaining that the company's Monsanto unit is reneging on an $11B settlement plan for resolving ...
Original post Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...
Bayer ( OTCPK:BAYRY -1.6% ) has agreed to settle ~90% of the 39K claims in the U.S. over alleged injuries related to its Essure permanent implanted birth control device. More news on: Bayer Aktiengesellschaft, Healthcare stocks news, Read more ...
On script, BioMarin Pharmaceutical's ( BMRN -36.2% ) stumble with hemophilia A gene therapy candidate valoctogene roxaparvovec has stoked modest buying in other players in the space as investors perceive improved prospects from the sidelining of a key competitor. More news on: BioMarin P...
eIntroduction After recovering strongly along with the broader market after the COVID-19 crash, Bayer ( OTCPK:BAYRY , OTCPK:BAYZF ) shares are now back in no man's land. Data by YCharts This underperformance may almost come as a surprise, as there have recently been several possible...
The following slide deck was published by Bayer Aktiengesellschaft in conjunction with their 2020 Q2 earnings Read more ...
Bayer Aktiengesellschaft (BAYZF) Q2 2020 Results Conference Call August 04, 2020 08:00 AM ET Company Participants Oliver Maier - Investor Relations Werner Baumann - Chief Executive Officer Wolfgang Nickl - Chief Financial Officer Stefan Oelrich - President, Pharmaceuticals Divi...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG ADR Company Name:
BAYRY Stock Symbol:
OTCMKTS Market:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...